SNWV News and Press, Sanuwave Health Inc

2026-01-27 07:30:00 ET The following segment was excerpted from the Deep Sail Capital Q4 2025 Investor Letter. ... Read the full article on Seeking Alpha For further details see: Sanuwave: A Compelling Asymmetric Opportunity In Advanced Wound Care

2026-01-15 05:10:00 ET Dear partners, Thank you for your continued trust and support; you are the best partners I could ask for. If you know anyone who would be a good fit for the fund, feel free to forward on this letter.... Read the full article on Seeking Alpha For fu...

2026-01-09 06:18:29 ET More on SANUWAVE Health SANUWAVE Health, Inc. 2025 Q3 - Results - Earnings Call Presentation SANUWAVE Health, Inc. (SNWV) Q3 2025 Earnings Call Transcript SANUWAVE targets $13M–$14M Q4 revenue while leveraging post-CMS rule clarity ...

Sanuwave is pleased to announce preliminary revenues of $13.3 million to $13.4 million for the fourth quarter ended December 31, 2025. This represents the highest quarterly revenues in Company history. Q4 2025 revenue increased between 29% and 30% compared to Q4 2024. Full Year 2025 reven...

EDEN PRAIRIE, Minn., Dec. 10, 2025 (GLOBE NEWSWIRE) -- Sanuwave Health, Inc. (the "Company" or "Sanuwave”) (NASDAQ: SNWV), a leading provider of FDA-approved next-generation wound care products, is pleased to announce that it will be attending the upcoming 44 th Annual J.P. Morgan ...

Healogics Wound Care Supply adds UltraMIST to its Group Purchasing Organization Healogics iSupply and Sanuwave collaborate to provide UltraMIST as an option for GPO members EDEN PRAIRIE, Minn., Dec. 08, 2025 (GLOBE NEWSWIRE) -- Sanuwave Health, Inc. (the "Company" or "Sanuwave&#...

2025-11-07 13:56:58 ET More on SANUWAVE Health SANUWAVE Health, Inc. (SNWV) Q3 2025 Earnings Call Transcript SANUWAVE Health, Inc. (SNWV) Q3 2025 Earnings Call Transcript Sanuwave: A Long-Term Compounder In Its Early Stages Sanuwave Health expects Q3 revenue ...

2025-11-07 06:28:36 ET More on SANUWAVE Health SANUWAVE Health, Inc. (SNWV) Q3 2025 Earnings Call Transcript Sanuwave: A Long-Term Compounder In Its Early Stages Sanuwave Health expects Q3 revenue between $11.4M and $11.6M Sanuwave refinances debt with new cr...

1stdibs.com Inc. (DIBS) is expected to report $-0.13 for Q3 2025 Delek Logistics Partners L.P. representing Limited Partner Interests (DKL) is expected to report $1.11 for Q3 2025 Claritev Corp Cl A (New) (CTEV) is expected to report $-3.12 for Q3 2025 AirSculpt Technologies Inc. (AIR...

Q3 2025 revenues were $11.5 million , up 22% from $9.4 million in Q3 2024. This represents the highest quarterly revenues in Company history. Q3 2025 gross margin was 77.9% , versus 75.5% in Q3 2024. GAAP Operating Income was $1.5 millio...